Free Trial

More results...

Filter by Content types

Alerts LATEST ALERTS

  • China - United States Modified trade tariffs temporarily suspended ...
  • Indonesia Tobacco products subject to promotional restrictions ...
  • Alabama - United States Bill to ban sales via vending machine heads to governor ...
  • Maryland - United States Baltimore sues PMI for marketing Zyn pouches to kids ...
  • United States Study shows increase in pouch use among high school students ...
  • Iran New tax rates on tobacco products announced ...
  • Slovenia New excise tax on tobacco products from 1st June ...
  • South Africa Nedlac to give input on tobacco bill this week ...
  • Russia Bill aims to ban sales of tobacco products at public transport stops ...
  • Italy ADM confirms all nic pouches subject to labelling and packaging rules ...
  • United States Surgeon general nominee’s view on novel nicotine products unclear ...
  • Indonesia Government withdraws proposal for plain packaging ...
News analysis

PMI allowed to make modified risk claims in US for Iqos 3 but import ban stands

Written by || 15th March 2022 || News analysis | Iqos | GeographiesNorth America United States

The US Food and Drug Administration (FDA) is allowing Philip Morris International (PMI) to market its Iqos 3 heated tobacco device with some reduced risk claims. The decision does not override the current ban by the International Trade Commission (ITC) on Iqos sales and imports but opens the door for the company to cite the authorisation in future marketing.

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber
Author default picture

TobaccoIntelligence

This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.